![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 31, 23933-23938, August 4, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Physiology, The Johns Hopkins University
School of Medicine, Baltimore, Maryland 21205
Received for publication, March 28, 2000, and in revised form, April 27, 2000
We have solubilized and purified the
histidine-tagged yeast secretory pathway/Golgi ion pump Pmr1 to near
homogeneity in one step, using nickel affinity chromatography. The
purified pump demonstrates both Ca2+- and
Mn2+-dependent ATP hydrolysis and phosphoenzyme
intermediate formation in forward (ATP) and reverse (Pi)
directions. This preparation has allowed us to examine, in detail, the
properties of mutations D778A and Q783A in transmembrane segment M6 of
Pmr1. In phenotypic screens of Ca2+ chelator and
Mn2+ toxicity reported separately (Wei, Y., Chen, J.,
Rosas, G., Tompkins, D.A., Holt, P.A., and Rao, R. (2000) J. Biol.
Chem. 275, XXXX-XXXX), D778A was a loss-of-function mutant
apparently defective for transport of both Ca2+ and
Mn2+, whereas mutant Q783A displayed a differential
sensitivity consistent with the selective loss of Mn2+
transport. We show that mutant D778A is devoid of
cation-dependent ATP hydrolytic activity and phosphoenzyme
formation from ATP. However, reverse phosphorylation from
Pi is preserved but is insensitive to inhibition by
Ca2+ or Mn2+ ions, which is evidence for a
specific inability to bind cations in this mutant. We also show that
Ca2+ can activate ATP hydrolysis in the purified Q783A
mutant, with a half-maximal concentration of 0.06 µM,
essentially identical to that of wild type (0.07 µM).
Mn2+ activation of ATP hydrolysis was half-maximal at 0.02 µM in wild type, establishing a normal selectivity
profile of Mn2+ > Ca2+. Strikingly,
Mn2+-ATPase in the Q783A mutant was nearly abolished, even
at concentrations of up to 10 µM. These results were
confirmed in assays of phosphoenzyme intermediates. Molecular modeling
of the packing between helices M4 and M6 suggests that residue
Gln783 in M6 may form a critical hydrophobic interaction
with Val335 in M4, such that the Ala substitution modifies
the packing or tilt of the helices and thus the ion pore. The data
emphasize the critical role of transmembrane segment M6 in defining the cation binding pocket of P-type ATPases.
In recent years, there has been a growing awareness of
Mn2+ as an effective surrogate for Ca2+
in supporting cell growth (1, 2). The ionic radius and coordination
chemistry of Mn2+ is closer to that of Ca2+
than other physiological cations, and both Ca2+ and
Mn2+ bind to oxygen- and nitrogen-based ligands on proteins
(3-6). Support for speculation that Mn2+ and
Ca2+ can function interchangeably in signal transduction
comes from observations that Mn2+ can replace
Ca2+ in a number of well established signaling systems,
including calmodulin activation (7), cyclic nucleotide metabolism (8), and secretion (9). In yeast, free Mn2+ was shown to be
500-1000-fold more effective than free Ca2+ in supporting
bud development and cell cycle progression (1). Manganese is believed
to be abundantly available in the natural habitat of yeast, at an
estimated concentration of 100 µM in rotting vegetation
(6, 10), and may well play a physiologically relevant role in mediating
cell growth. Thus, the mobilization and transport of Mn2+
are likely to emulate that of Ca2+ (11).
The yeast ion pump Pmr1, which localizes to the medial Golgi, has been
implicated in the delivery of both Ca2+ and
Mn2+ to the secretory pathway (2, 12), where they have
distinct roles in sustaining protein sorting (Ca2+) or
protein glycosylation (Mn2+). Cytosolic Mn2+
accumulates in pmr1 mutants and can serve as an inorganic
scavenger of superoxide radicals, thus bypassing the requirement for
cytosolic superoxide dismutase in aerobic growth (12). Consequently,
pmr1 mutants also display hypersensitivity to the growth
toxicity of millimolar concentrations of extracellular
Mn2+, indicating that delivery into the secretory pathway
by Pmr1, and subsequent exocytosis, must be a major route for cellular detoxification of Mn2+. In earlier work, we have
demonstrated that Mn2+ is a potent inhibitor of
Pmr1-mediated 45Ca2+ transport in isolated
Golgi vesicles, consistent with competition for transport sites
(13).
In the accompanying work (14), we have taken advantage of the
hypersensitivity of the pmr1 null strain to
BAPTA1 and Mn2+
toxicity and screened for mutants defective in cation transport and
selectivity (14). The identification of the mutation Q783A in
transmembrane segment M6 of Pmr1, which conferred hypersensitivity to
Mn2+ toxicity but retained normal 45Ca
transport characteristics, provided a preliminary insight into the
molecular basis of ion selectivity in transport ATPases (14). Several
loss-of-function mutants, resembling the null strain in both BAPTA and
Mn2+ hypersensitivity, were also identified. One such
mutant, D778A, again in M6, retained normal biogenesis and ATP binding
ability but had no detectable transport activity (14). This residue is
conserved in all Pmr1 homologues sequenced to date and likely contributes directly to cation binding, analogous to the proposed role
of the equivalent aspartate in SERCA and the
Na+/K+-ATPase (15, 16). Here, we describe the
solubilization and purification of His-tagged Pmr1, by nickel affinity
chromatography. The purified preparations were used to assay
cation-dependent ATP hydrolysis and phosphoenzyme formation
in wild type and mutants D778A and Q783A. The data support a critical
role for Asp778 in the cation-binding pocket and
demonstrate a striking reversal in ion selectivity for the Q783A
mutant. The phenotype of additional substitutions at residue 783 have
led us to hypothesize a role for this residue in M4-M6 helix packing,
which is supported by molecular modeling simulation.
Media, Strains, and Plasmids
Cultures were grown in defined minimal media containing yeast
nitrogen base (6.7 g/liter; Difco), dextrose (2%), and
supplements as needed. Growth assays in BAPTA- and
Mn2+-supplemented medium were done exactly as
described (14). Yeast strain K616
( Solubilization and Purification of Histidine-tagged Pmr1
Isolation of Golgi membranes by sucrose density gradient
centrifugation of clarified yeast lysates was exactly as described earlier (19). A crude detergent extract was prepared by suspending 1 mg
of Golgi membranes in 1 ml of solubilization buffer S
containing 20 mM Hepes/Tris, pH 7.0, 20% glycerol,
0.5% Escherichia coli total lipid extract, 1.5%
n-octyl- Meanwhile, 0.1 ml of bed volume of Ni-NTA-agarose (Qiagen) was placed
in a 2-ml microcentrifuge tube and washed twice with 0.5 ml of cold
water and washed twice with 1 ml of buffer S plus 10 mM imidazole. The detergent extract was added to the
equilibrated resin and incubated at 4 °C for 2.5 h with gentle
shaking. The mixture was then transferred to a 2-ml Micro Bio-Spin
column (Bio-Rad), and unbound material was collected by gravity
elution. The column was washed with 20 column volumes of Wash Buffer
(Buffer S plus 200 mM NaCl and 50 mM
imidazole) to release nonspecifically bound material.
His9-Pmr1 was eluted following incubation with 0.2-0.3 ml
of elution buffer (Buffer S plus 300 mM
imidazole) for 5 min. The eluted material was collected by
centrifugation at 1000 × g for 30 s in a
refrigerated microcentrifuge, immediately frozen in a dry
ice/ethanol bath, and stored at [ The method of Ghosh et al. (21) was followed, with
some modifications. Here, the assay mixture was reduced to 0.1 ml and contained 50 mM Hepes/Tris, pH 7.0, 100 mM KCl,
and 1 mM MgCl2. Cations (Ca2+ and
Mn2+) were added as the chloride salts and buffered with
EGTA as specified in the figure legends; free cation
concentration was determined by the WinMaxChelator computer program
(22). Ni-NTA eluted Pmr1 (1 µg) was preincubated in the reaction
mixture at room temperature, and ATP hydrolysis was initiated by the
addition of 5 µl of 1 mM [ Enzyme Phosphorylation
Phosphorylation with ATP--
Formation of the
aspartyl-phosphate reaction intermediate was assayed as described (23),
with some modifications. The 0.2-ml reaction mixture contained 25 mM Hepes/Tris, pH 7.0, 100 mM KCl, and 1 µg
of purified Pmr1. To test cation dependence, EGTA was added to a final
concentration of 1 mM such that the free Ca2+
concentration was less than 1 nM. Then 1 mM
CaCl2 or MnCl2 was added to give free cation
concentrations of 27 or 6 µM, respectively. The reaction
was started by the addition of 10 µCi of [ Phosphorylation with Pi--
Reverse phosphorylation
of Pmr1 was performed according to Hawkins et al. (25). The
reaction mixture of 0.2 ml contained 50 mM Hepes/Tris, pH
7.0, 100 mM KCl, 5 mM MgCl2, 20%
(v/v) dimethyl sulfoxide, and one of the following: EGTA (5 mM) or CaCl2 or MnCl2 (100 µM). Phosphorylation was initiated by the addition of 200 µM 32Pi (1500-2000 cpm/pmol) at
25 °C for 5 min. The reaction was terminated by addition of 15%
trichloroacetic acid and 2 mM
KH2PO4 and incubated on ice for 15 min. After
microcentrifugation, the pellet was treated as described for
ATP-dependent (forward) phosphorylation and subjected to
acid gel electrophoresis and autoradiography.
Gel Electrophoresis, Western Blotting, and Other Biochemical
Assays
SDS-PAGE and Western blotting were performed as described
previously (26). Samples were prepared for electrophoresis by precipitating with trichloroacetic acid to a final concentration at
10% by volume, followed by microcentrifugation at 4 °C. Antibodies against the C-terminal one-third of Pmr1 have been described previously (19). Silver staining was performed according to Blum et al. (27). Protein concentration was determined by a modification of the
method of Lowry et al. (28).
Ab Initio Molecular Modeling of M4 and M6
A recently developed algorithm (29) was used to simulate packing
of the M4 and M6 helices of Pmr1. Briefly, a reduced representation of
the two helices was used in the first stage of modeling to simplify the
search space. Each amino acid in a helix was considered to be a sphere
with an empirically assigned volume that captures its packing
attributes (30). The ball-helix representation used a simple model for
the membrane bilayer, with the interior based on the
Goldman-Engelman-Steitz transfer scale (31) and the interface based on
the Wimley-White scale (32). Over 350,000 independent helix-pair
combinations were explored to eliminate sterically "impossible"
combinations. In the next stage, a more realistic representation of the
membrane environment was applied, along with a more detailed protein
representation. Finally, constraints were imposed based on experimental
data from Cys cross-linking in SERCA (33) and mutagenesis of
cation-coordinating residues in M4 and M6, as depicted in Fig. 8.
Purification of Histidine-tagged Pmr1
A 15-residue extension of the N terminus of Pmr1, having the
sequence RGSQH9TR immediately following the initiating Met,
was constructed in earlier work (13). We showed that introduction of
this polyhistidine tag had no effect on the biogenesis and Golgi localization of Pmr1, as determined by subcellular fractionation of yeast lysates, and on the overall protein conformation, as evidenced
by the pattern of ATP-protectable tryptic cleavage (13). Furthermore,
Vmax and Km for
45Ca transport were identical to that reported earlier for
untagged Pmr1 (13, 19). Here, we describe the purification of
His-tagged Pmr1 by nickel affinity chromatography, in essentially one
step. Golgi membrane fractions, derived from sucrose density gradient centrifugation of yeast lysates (19), were pooled and treated with the
detergent n-octylglucoside, resulting in the solubilization of up to 70% of Pmr1 (Fig. 1). The
supernatant was allowed to interact with Ni-NTA resin, as described
under "Experimental Procedures." The inclusion of 10 mM
imidazole during this incubation was found to greatly reduce
nonspecific protein interactions with the resin while preserving
complete retention of His-Pmr1. After washing the resin with salt and
additional imidazole ("Experimental Procedures"), His-Pmr1 was
eluted at >95% purity in buffer containing 300 mM imidazole, as judged from silver stains and Western blots of SDS-PAGE (Fig. 1). Yields of Pmr1 protein averaged 30 µg/liter of culture (approximately 600 OD units), consistent with an estimated expression level of about 5% in Golgi membranes.
Cation Dependence of Pmr1 Activity
ATP Hydrolysis--
The availability of a purified preparation of
Pmr1 allowed an unambiguous demonstration of
cation-dependent ATP hydrolyis, using a sensitive
isotope-based method ("Experimental Procedures"). ATPase activity
was strictly dependent on the presence of either Mn2+ or
Ca2+ and was linear within the first 30 s (Fig.
2). The presence of 500 µM
vanadate (not shown) or 100 µM La3+ (Fig. 2)
nearly abolished ATP hydrolysis, similar to the effect of these
inhibitors on ATP-dependent 45Ca transport in
Golgi vesicles (19). No ATPase activity was observed with 10 µM concentrations of either Ba2+,
Sr2+, Zn2+, Cd2+, Ni2+,
or Cu2+, demonstrating the narrow cation selectivity
profile of the pump.
Formation of the Phosphoenzyme Intermediate--
A hallmark of
P-type ATPases is the formation of a transient aspartyl-phosphate
reaction intermediate, at an invariant aspartate located in the large
hydrophilic domain closely following membrane span M4. Consistent with
an obligatory role for this residue, we have shown that replacement of
Asp371 in Pmr1 with asparagine or glutamate completely
inactivates transport (19). Here, we demonstrate phosphoenzyme
formation in the purified, His-tagged enzyme. In the forward reaction,
formation of the E~P intermediate from ATP requires activation by
either Ca2+ or Mn2+ (Fig.
3A). Addition of
La3+ resulted in only modest increases in the accumulation
of phosphoenzyme, unlike the large effect documented for plasma
membrane type Ca2+-ATPases (34). The aspartyl-phosphate
intermediate could be completely chased with excess unlabeled ATP (Fig.
3A) and nonenzymatically cleaved with hydroxylamine (not
shown). Conversely, in the reverse reaction, formation of E-P from
inorganic phosphate (Pi) was inhibited by Ca2+
and Mn2+ (Fig. 3B), which shift the equilibrium
toward the E1 conformation.
Manganese Selectivity of Pmr1, the Yeast Secretory Pathway Ion
Pump, Is Defined by Residue Gln783 in Transmembrane
Segment 6
RESIDUE Asp778 IS ESSENTIAL FOR CATION
TRANSPORT*
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
pmr1
pmc1
cnb1) was
used as host and has been described before (17). Plasmid YCpHR1 is a
centromeric yeast plasmid carrying the PMR1 gene under heat
shock control (14). Mutations Q783A and D778A were made earlier (14);
additional substitutions of Gln783 with Leu, Glu, Thr, Asn,
Ser, and Cys were made by the "inverse polymerase chain reaction"
method using a pair of oligonucleotides in each case (18). Mutations
were confirmed by DNA sequencing and introduced into plasmid YCpHR1 by
standard cloning techniques. Plasmid YEpHisPMR1 is a 2µ plasmid
expressing the N-terminal His9-tagged Pmr1 behind the
constitutive PGK promoter and has been described earlier
(13). Briefly, it was constructed by replacing the initiator ATG codon
in PMR1 with a unique MluI site and cloning into
the expression vector pSM1052 (gift of Susan Michaelis, Johns Hopkins University). This construct results in a 15-residue N-terminal extension of Pmr1 having the sequence RGSQHHHHHHHHHTR following the
initiating Met. Mutations Q783A and D778A were introduced into
YEpHisPMR1 by cloning a 3-kilobase pair BamHI fragment
containing the mutation from the YEpHR1 construct (14) and verifying
correct orientation by restriction analysis.
-D-glucopyranoside, 6 mM
mercaptoethanol, and protease inhibitors (20). The resulting suspension was mixed for 2 h on a rotary motor at 4 °C. The
mixture was cleared of unextractable materials by centrifugation at
100,000 × g for 1 h at 4 °C.
80 °C until further use.
-32P]ATP Hydrolysis
-32P]ATP (3000 Ci/mmol; Amersham Pharmacia Biotech) to a final concentration of
50 µM (500-600 cpm/pmol). After the desired incubation
period, the reaction was terminated with 10 µl of 25%
trichloroacetic acid, followed by the addition of 10 µl of 100 mM KH2PO4. Then 0.1 ml of a
suspension of activated charcoal (1:1 in water; Sigma) was added. After
mild stirring for 10 min, the charcoal was precipitated by
centrifugation in a microcentrifuge. The process was repeated once, and
finally an aliquot from the supernatant was transferred to 10 ml of
scintilation mixture (Ecolume; ICN), and the radioactivity was
determined by scintillation counting.
-32P]ATP,
to a final concentration of 10 nmol/reaction, on ice. The reaction was
terminated after 30 s by adding 0.2 ml of 50 mM
NaH2PO4, 2 mM ATP, and 20%
trichloroacetic acid. The resulting precipitate was pelleted by
microcentrifugation and washed twice with a solution containing 25 mM NaH2PO4, 1 mM ATP,
and 10% trichloroacetic acid. The pellet was finally resuspended in 20 µl of sample buffer and subjected to SDS-polyacrylamide gel
electrophoresis at pH 6.0 according to the method of Weber and Osborn
(24). The gel was dried, and the radioactivity was detected on a
PhosphorImager (Fuji).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (74K):
[in a new window]
Fig. 1.
Solubilization and purification of
histidine-tagged Pmr1. Crude Golgi membranes were prepared from
sucrose density gradients of yeast lysates solubilized with
octylglucoside, and the supernatant was subjected to Ni-NTA
chromatography, as described under "Experimental Procedures."
10-µg samples of crude, pellet, supernatant, column flowthrough, and
wash and 1 µg of column eluate were separated by SDS-PAGE. Molecular
mass markers are shown on the far right.
A, silver-stained gel. B, Western blot probed
with polyclonal anti-Pmr1 antibody.

View larger version (17K):
[in a new window]
Fig. 2.
Time course of cation-dependent
ATP hydrolysis. Ni-NTA eluted Pmr1 (1 µg) was incubated with
[
-32P]ATP (50 µM; 500 cpm/pmol) at room
temperature for the indicated times, and the released P04
was quantitated as described in the text. CaCl2 and
MnCl2 were at 950 µM each and buffered with 1 mM EGTA to give free cation concentrations of 6 µM each. Where indicated, LaCl3 was added to
a final concentration of 100 µM.
, Mn2+;
, Ca2+;
, Ca2+ plus La3+.
Lines are the best fit of the data to the Michaelis-Menten
equation. Averages of duplicate determinations are shown, and data are
representative of one of three independent experiments.

View larger version (22K):
[in a new window]
Fig. 3.
Formation of the phosphoenzyme
intermediate. A, Cation-dependent
phosphoprotein formation from [
-32P]ATP. Ni-NTA eluted
Pmr1 (1 µg) was incubated on ice for 30 s with 10 nM
[
-32P]ATP in 20 mM Hepes/Tris, pH 7.0, 100 mM KCl, 1 mM EGTA, and 1 mM
divalent cation, as indicated, to give a final free concentration of 27 µM Ca2+ and 6 µM
Mn2+. The reaction was stopped by acid quench and analyzed
by SDS-PAGE and autoradiography. Where indicated, LaCl3 was
added to a final concentration of 100 µM. The E~P
intermediate can be completely chased with unlabeled ATP (10 mM). B, cation-inhibitable phosphoprotein
formation from Pi. The reaction differed from A,
in having 250 µM
[32P]H3PO4 plus 20% dimethyl
sulfoxide and was incubated at 25 °C for 5 min. Divalent cations
were at 1 mM concentrations, as indicated.
Loss of Cation Binding in the D778A Mutant
Substitution of Asp778, conserved in all known
Ca2+-ATPases, with either alanine, asparagine, or
glutamate, resulted in a complete loss of transport activity consistent
with the loss-of-function phenotype in screens of BAPTA and
Mn2+ toxicity (14). However, to demonstrate a role for this
residue in cation binding, it was necessary to examine
cation-dependent formation of the catalytic intermediate.
We first showed that mutant D778A was normal with respect to
biogenesis, trafficking, and overall protein conformation (14). Next,
mutant D778A was tagged with polyhistidine and purified, as described
for wild type Pmr1. As expected, there was a complete absence of ATP
hydrolysis in the purified mutant (not shown). Fig.
4 demonstrates an inability of this
mutant to form the cation-activated phosphoenzyme intermediate from
ATP, whereas reverse phosphorylation from inorganic phosphate is
retained. Strikingly, reverse phosphorylation is insensitive to
inhibition by cation (Ca2+ and Mn2+),
indicative of a loss of cation binding (15).
|
Loss of Manganese Selectivity in the Q783A Mutant
In the phenotypic screens reported earlier, mutant Q783A appeared
similar to wild type in BAPTA tolerance but was indistinguishable from
the pmr1 null strain in Mn2+ tolerance,
suggesting a selective loss of Mn2+ transport (14).
Furthermore, Mn2+ inhibition of 45Ca transport
in Golgi vesicles was decreased by 60-fold, suggestive of a severe
defect in Mn2+ binding or transport in this mutant (14).
Here, we demonstrate a dramatic change in ion selectivity of the mutant
pump by direct assay of cation-dependent ATPase activity in
histidine-tagged and purified preparations of wild type and Q783A
enzymes. Wild type Pmr1 displayed a Km of 0.07 µM for Ca2+-dependent ATP
hydrolysis, identical to the Km for 45Ca
transport reported earlier (13). Both Km and
Vmax of Ca2+-dependent
ATPase activity in the Q783A mutant were essentially indistinguishable
from wild type, as expected from the growth response to BAPTA in this
mutant (Fig. 5A).
Mn2+-dependent ATPase activity in wild type had
a Km of 0.02 µM, indicative of a
normal selectivity of Mn2+ > Ca2+ for the
Golgi/secretory pathway pump. In striking contrast,
Mn2+-ATPase in the mutant was nearly abolished (Fig.
5B). We also show normal levels of
Ca2+-activated phosphoenzyme formation from ATP in this
mutant, whereas Mn2+ was required in excess (10 µM) to detect the catalytic intermediate (Fig.
6). Taken together, the data strongly
indicate that residue 783 in M6 can define ion selectivity in Pmr1.
|
|
Phenotypic Consequences of Amino Acid Substitutions at Residue 783 in M6--
To further explore the effect of amino acid substitutions at
position 783 on ion selectivity of the pump, additional mutations of
Gln783 to Leu, Glu, Thr, Asn, Cys, and Ser were generated
in the PMR1 gene. These substitutions were chosen to test
the effect of side chain size, hydrophobicity, or charge. Mutants were
expressed from the low copy vector YCpHR1 in the
pmr1pmc1cnb1 null strain K616 and screened for tolerance to
BAPTA and Mn2+ as a test of Ca2+ and
Mn2+ transport, respectively (14). As shown in Fig.
7, only the Ala substitution resulted in
a differential response to BAPTA and Mn2+ toxicity,
indicative of a change in ion selectivity. Substitutions to Leu, Glu,
or Thr showed substantial and parallel growth in both phenotypic
screens, whereas substitutions to Asn, Ser, or Cys showed a
hypersensitivity to BAPTA and Mn2+ toxicity
indistinguishable from the pmr1 null strain. Western analysis of total membrane preparations revealed that expression of the
Leu, Glu, and Thr substitutions were similar to wild type, whereas
substitutions to Asn, Ser, and Cys showed a significant decrease in
abundance, suggestive of structural perturbations (not shown). These
data reveal the importance of a bulky side chain (Gln, Leu, Glu, or
Thr) at position 783 in M6 for effective transport of both
Ca2+ and Mn2+ ions. Charge appears to be
unimportant because both Leu and Glu can effectively substitute for Gln
at this site. Conversely, introduction of a small, polar side chain at
this site appears deleterious to pump structure and function.
Interestingly, the small nonpolar side chain of alanine
maintained normal pump structure but apparently altered pore
characteristics such that Mn2+ transport was selectively
lost.
|
| |
DISCUSSION |
|---|
|
|
|---|
Of the five polar or charged residues in transmembrane segment M6, three (Asn774, Asp778, and Gln783) were found to be critical for pump function (14). The importance of M6 is underscored by a striking conservation of sequence among Pmr1 homologues, which include representatives from four other fungi and one each from C. elegans, rat, and human; with the exception of an Ile substitution for Leu, there is complete identity within the predicted M6 segment. Of the three Ca2+-liganding residues (Asn796, Thr799, and Asp800) in M6 of SERCA, originally identified by Clarke et al. (15), two (Asn774 and Asp778) are conserved and sensitive to substitution in the Golgi/secretory pathway ion pump. Replacement of the equivalent residues in the plasma membrane Ca2+ pump (plasma membrane Ca2+-ATPase) have also been reported to inactivate transport and prevent phosphoenzyme formation from ATP (34, 35). Together with the conserved glutamate in M4 (Glu329 in Pmr1), these three residues are likely to contribute to the binding of one Ca2+ ion in all three Ca2+-ATPase subtypes. In SERCA, this site would be equivalent to binding site II, the more cytoplasmic of two stacked sites (36, 37). A subset of these residues also appear to contribute to ion binding in P-type ATPases of different ion selectivities. Thus, Asp804 and Asp808 in M6 of the Na+/K+-ATPase have been proposed to play a key role in cation transport and in binding K+ ions in particular (16). These observations have been corroborated by the mutagenesis of equivalent residues in the H+/K+-ATPase (38). The differential contribution of other residues to this common cation binding pocket may alter ion binding characteristics and account for the widely different ion selectivities among the P-ATPases. Thus, replacement of Ser775 in M5 of the Na+/K+-ATPase had a profound effect on K+ binding (39), but mutation of the equivalent residue in Pmr1 (S774A) had no effect on Ca2+ or Mn2+ transport (14). Identifying the residues that contribute to ion selectivity remains a challenge in the field.
We report here that substitution of Gln783 with alanine
results in a dramatic and selective loss of Mn2+- but not
Ca2+-dependent ATPase activity and
phosphoenzyme formation. We show that glutamine can be effectively
replaced with either Leu (the equivalent residue in plasma membrane
Ca2+-ATPase) or Thr (the equivalent residue in SERCA),
suggesting that Mn2+ transport may be a common feature of
all Ca2+ pump subtypes. The restoration of Mn2+
tolerance to a pmr1 mutant by heterologous expression of a
plant homologue of SERCA, ECA1 (23), is consistent with this
possibility. Curiously, introduction of an acidic residue (Glu) at this
site preserved wild type phenotype, whereas small polar residues (Cys, Ser, or Asn) appeared to be deleterious to pump structure, based on the
large reduction of Pmr1 expression levels. Because a helical representation of M6 placed Gln783 on the opposite face
from the cation coordinating residues, we considered the possibility
that this residue may be important in helix packing. Therefore, we
simulated the packing interactions between transmembrane segments M4
and M6 ("Experimental Procedures"), using data from cysteine
cross-links (33) to impose constraints on the models. Fig.
8 is an alignment of Pmr1 sequence with
that of SERCA, showing the excellent conservation in the regions
identified by strong cross-links between engineered Cys in
transmembrane segments M4 and M6 of SERCA.
|
In a hierarchical approach to ab initio structure
prediction, we began with a reduced representation of the helices in
which each amino acid was empirically assigned a spherical volume,
characteristic of its packing attributes. Likewise, a reduced
representation of the membrane environment was used ("Experimental
Procedures") to simplify the search space. This allowed over 350,000 candidate conformations to be tested in the first stage, resulting in
the elimination of all sterically impossible combinations. Following a
second modeling stage that employed a more detailed protein and
membrane representation, we imposed experimental constraints from Cys
cross-linking and orientation of cation coordinating residues (Fig. 8).
Of the dozen or so plausible models that emerged, Fig.
9 represents the minimum energy structure
and has several interesting features. The helices interact with a
right-handed twist, consistent with the interpretation of electron
diffraction densities reported by Zhang et al. (40). Neither
M4 nor M6 are uniform helices; both display a significant unraveling in
the vicinities of the prolines, followed by a change in backbone
direction. Of particular interest to this work is the location of
Gln783 in the model. Fig. 9 suggests that
Gln783 (M6) may form a hydrophobic contact with
Val335 (M4), possibly stabilizing the helical
interaction.
|
It should be emphasized that although our tertiary structure prediction
does not take into account other transmembrane helices or consider
significant deviations from helical structure, it does satisfy our
currrent experimental observations and therefore provides a testable
model for future experiments. Thus, it suggests that the hydrophobic
interaction with Val335 may be maintained by the longer
methyl- or methylene-containing side chains of Glu, Leu, or Thr but
would be disrupted by introduction of shorter side chains carrying the
polar amine (Asn), sulfhydryl (Cys), or hydroxyl (Ser) groups. Alanine
substitution may maintain the hydrophobic interaction but with likely
alterations in helix packing. We suggest that these changes would have
repercussions on the architecture of the ion pore and hence on ion
selectivity. The arrangement and tilt of the helices may be expected to
have a profound effect on ion selectivity, as suggested by the recent structure of the KcsA K+ channel (41). In experiments
currently underway in our laboratory, we are engineering reciprocal
alterations in M4 in an attempt to suppress the
Mn2+-sensitive phenotype of Pmr1 mutant Q783A.
| |
FOOTNOTES |
|---|
* This work was supported by American Cancer Society Grants IRG11-33 and JFRA 538, American Heart Association Grant-In-aid 95012290, and National Institutes of Health Grant GM52414 (to R. R.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Physiology,
Johns Hopkins University School of Medicine, 725 N. Wolfe St.,
Baltimore MD 21205. Tel.: 410-955-4732; Fax: 410-955-0461; E-mail:
rrao@jhmi.edu.
Published, JBC Papers in Press, May 5, 2000, DOI 10.1074/jbc.M002619200
| |
ABBREVIATIONS |
|---|
The abbreviations used are: BAPTA, 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid; PAGE, polyacrylamide gel electrophoresis; SERCA, sarco/endoplasmic reticulum Ca2+-ATPase; Ni-NTA, nickel-nitrilotriacetic acid.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Loukin, S., and Kung, C. (1995) J. Cell Biol. 131, 1025-1037 |
| 2. | Durr, G., Strayle, J., Plemper, R., Elbs, S., Klee, S. K., Catty, P., Wolf, D. H., and Rudolph, H. K. (1998) Mol. Biol. Cell 9, 1149-1162 |
| 3. | Osterberg, R. (1974) in Metal Ions in Biological Systems: High Molecular Complexes (Siegel, H., ed), Vol. 3 , pp. 45-88, Marcel Dekker, Inc., New York |
| 4. | Lawrence, G. D., and Sawyer, D. T. (1978) Coordination Chem. Rev. 27, 173-193 |
| 5. | Williams, R. J. P. (1982) FEBS Lett. 140, 3-10 |
| 6. | Reed, G. H. (1986) in Manganese in Metabolism and Enzyme Function (Schramm, V. L. , and Wedler, F. C., eds) , pp. 313-323, Academic Press, Inc., San Diego, CA |
| 7. | Kawasaki, H., Kuroso, Y., Kasai, H., Isobe, T., and Okuyama, T. (1986) J. Biochem. (Tokyo) 99, 1409-1416 |
| 8. | Keller, C. H., LaPorte, D. C., Toscano, W. A., Jr., Storm, D. R., and Westcott, K. R. (1980) Ann. N. Y. Acad. Sci. 356, 205-219 |
| 9. | Wilson, S. P., and Kirshner, M. (1983) J. Biol. Chem. 258, 4994-5000 |
| 10. | Loneragan, J. F. (1988) in Manganese in Soil and Plants (Graham, R. D. , Hannam, R. J. , and Uren, N. C., eds) , pp. 113-124, Kluwer Academic Publishers, Dordrecht, The Netherlands |
| 11. | Luckhoff, A., and Clapham, D. E. (1992) Nature 335, 356-358 |
| 12. | Lapinskas, P. J., Cunningham, K. W., Liu, X. F., Fink, G. R., and Culotta, V. C. (1995) Mol. Cell. Biol. 15, 1382-1388 |
| 13. | Wei, Y., Marchi, V., Wang, R., and Rao, R. (1999) Biochemistry 38, 14534-14541 |
| 14. | Wei, Y., Chen, J., Rosas, G., Tompkins, D. A., Holt, P. A., and Rao, R. (2000) J. Biol. Chem. 275, 23927-23932 |
| 15. | Clarke, D. M., Loo, T. W., Inesi, G., and MacLennan, D. H. (1989) Nature 339, 476-478 |
| 16. | Kuntzweiler, T. A., Arguello, J. M., and Lingrel, J. B (1996) J. Biol. Chem. 271, 29682-29687 |
| 17. | Cunningham, K. W., and Fink, G. R. (1994) J. Cell Biol. 124, 351-363 |
| 18. | Fisher, C. L., and Pei, G. K. (1997) BioTechniques 23, 570-574 |
| 19. | Sorin, A., Rosas, G., and Rao, R. (1997) J. Biol. Chem. 272, 9895-9901 |
| 20. | Fu, D., and Maloney, P. C. (1997) J. Biol. Chem. 272, 2129-2135 |
| 21. | Ghosh, J., Ray, M., Sarkar, S., and Bhaduri, A. (1990) J. Biol. Chem. 265, 11345-11351 |
| 22. | Bers, D., Patton, C., and Nuccitelli, R. (1994) Methods Cell Biol. 40, 3-29 |
| 23. | Liang, F., Cunningham, K. W., Harper, J. F., and Sze, H. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 8579-8584 |
| 24. | Weber, K., and Osborn, M. (1969) J. Biol. Chem. 244, 4406-4412 |
| 25. | Hawkins, S. C., Xu, A., and Narayanan, N. (1994) Biochem. Biophys. Acta 1191, 231-243 |
| 26. | Nakamoto, R. K., Rao, R., and Slayman, C. W. (1991) J. Biol. Chem. 266, 7940-7949 |
| 27. | Blum, H., Beier, H., and Gros, H. J. (1987) Electrophoresis 8, 93-99 |
| 28. | Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951) J. Biol. Chem. 193, 265-275 |
| 29. | Woolf, T. B., Grossfield, A., and Sachs, J. N. (2000) Biophys. J. 78, 159 (abstr.) |
| 30. | Pontius, J., Richelle, J., and Wodak, S. J. (1996) J. Mol. Biol. 264, 121-136 |
| 31. | Engelman, D. M., Steitz, T. A., and Goldman, A. (1986) Annu. Rev. Biophys. Chem. 15, 321-353 |
| 32. | Wimley, W. C., and White, S. H. (1996) Nature Struct. Biol. 3, 842-848 |
| 33. | Rice, W. J., Green, N. M., and MacLennan, D. H. (1997) J. Biol. Chem. 272, 31412-31419 |
| 34. | Adebayo, A. O., Enyedi, A., Verma, A. K., Filoteo, A. G., and Penniston, J. T. (1995) J. Biol. Chem. 270, 27812-27816 |
| 35. | Guerini, D., Foletti, D., Vellani, F., and Carafoli, E. (1996) Biochemistry 35, 3290-3296 |
| 36. | Skerjanc, I. S., Toyofuku, T., Richardson, C., and MacLennan, D. H. (1993) J. Biol. Chem. 268, 15944-15950 |
| 37. | Andersen, J. P., and Vilsen, B. (1994) J. Biol. Chem. 269, 15931-15936 |
| 38. | Swarts, H. G., Klaassen, C. H., de Boer, M., Fransen, J. A., and De Pont, J. J. (1996) J. Biol. Chem. 271, 29764-29772 |
| 39. | Blostein, R., Wilczynska, A., Karlish, S. J. D., Arguello, J. M., and Lingrel, J. B. (1997) J. Biol. Chem. 272, 24987-24993 |
| 40. | Zhang, P., Toyoshima, C., Yonekura, K., Green, N. M., and Stokes, D. L. (1998) Nature 392, 835-839 |
| 41. | Doyle, D. A., Cabral, J. M., Pfuetzner, R. A., Kuo, A., Gulbis, J. M., Cohen, S. L., Chait, B. T., and MacKinnon, R. (1998) Science 280, 69-77 |
This article has been cited by other articles:
![]() |
H. Lin, A. Kumanovics, J. M. Nelson, D. E. Warner, D. M. Ward, and J. Kaplan A Single Amino Acid Change in the Yeast Vacuolar Metal Transporters Zrc1 and Cot1 Alters Their Substrate Specificity J. Biol. Chem., December 5, 2008; 283(49): 33865 - 33873. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Devasahayam, D. J. Burke, and T. W. Sturgill Golgi Manganese Transport Is Required for Rapamycin Signaling in Saccharomyces cerevisiae Genetics, September 1, 2007; 177(1): 231 - 238. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yadav, S. Muend, Y. Zhang, and R. Rao A Phenomics Approach in Yeast Links Proton and Calcium Pump Function in the Golgi Mol. Biol. Cell, April 1, 2007; 18(4): 1480 - 1489. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Dode, J. P. Andersen, L. Raeymaekers, L. Missiaen, B. Vilsen, and F. Wuytack Functional Comparison between Secretory Pathway Ca2+/Mn2+-ATPase (SPCA) 1 and Sarcoplasmic Reticulum Ca2+-ATPase (SERCA) 1 Isoforms by Steady-state and Transient Kinetic Analyses J. Biol. Chem., November 25, 2005; 280(47): 39124 - 39134. [Abstract] [Full Text] [PDF] |
||||
![]() |
V.-K. Ton and R. Rao Functional expression of heterologous proteins in yeast: insights into Ca2+ signaling and Ca2+-transporting ATPases Am J Physiol Cell Physiol, September 1, 2004; 287(3): C580 - C589. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. T. Jensen, M. Ajua-Alemanji, and V. C. Culotta The Saccharomyces cerevisiae High Affinity Phosphate Transporter Encoded by PHO84 Also Functions in Manganese Homeostasis J. Biol. Chem., October 24, 2003; 278(43): 42036 - 42040. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Fairclough, L. Dode, J. Vanoevelen, J. P. Andersen, L. Missiaen, L. Raeymaekers, F. Wuytack, and A. Hovnanian Effect of Hailey-Hailey Disease Mutations on the Function of a New Variant of Human Secretory Pathway Ca2+/Mn2+-ATPase (hSPCA1) J. Biol. Chem., June 27, 2003; 278(27): 24721 - 24730. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Delhaize, T. Kataoka, D. M. Hebb, R. G. White, and P. R. Ryan Genes Encoding Proteins of the Cation Diffusion Facilitator Family That Confer Manganese Tolerance PLANT CELL, May 1, 2003; 15(5): 1131 - 1142. [Abstract] [Full Text] |
||||
![]() |
Z. Wu, F. Liang, B. Hong, J. C. Young, M. R. Sussman, J. F. Harper, and H. Sze An Endoplasmic Reticulum-Bound Ca2+/Mn2+ Pump, ECA1, Supports Plant Growth and Confers Tolerance to Mn2+ Stress Plant Physiology, September 1, 2002; 130(1): 128 - 137. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yoshimoto, K. Saltsman, A. P. Gasch, H. X. Li, N. Ogawa, D. Botstein, P. O. Brown, and M. S. Cyert Genome-wide Analysis of Gene Expression Regulated by the Calcineurin/Crz1p Signaling Pathway in Saccharomyces cerevisiae J. Biol. Chem., August 16, 2002; 277(34): 31079 - 31088. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Cronin, R. Rao, and R. Y. Hampton Cod1p/Spf1p is a P-type ATPase involved in ER function and Ca2+ homeostasis J. Cell Biol., June 10, 2002; 157(6): 1017 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. White The pathways of calcium movement to the xylem J. Exp. Bot., May 1, 2001; 52(358): 891 - 899. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Van Baelen, J. Vanoevelen, L. Missiaen, L. Raeymaekers, and F. Wuytack The Golgi PMR1 P-type ATPase of Caenorhabditis elegans. IDENTIFICATION OF THE GENE AND DEMONSTRATION OF CALCIUM AND MANGANESE TRANSPORT J. Biol. Chem., March 30, 2001; 276(14): 10683 - 10691. [Abstract] [Full Text] [PDF] |
||||
| ||||||||